Silk Road Medical Inc. (SILK) Reports In-Line Q4 EPS, Revenues Beat; Provides FY20 Revenue Guidance

Go back to Silk Road Medical Inc. (SILK) Reports In-Line Q4 EPS, Revenues Beat; Provides FY20 Revenue Guidance
(NASDAQ: SILK) Delayed: 27.49 --0 (-0%)
Previous Close $27.49    52 Week High
Open $27.49    52 Week Low
Day High $27.49    P/E N/A 
Day Low $27.49    EPS
Volume 167